Tet-pLKO-puro-Scrambled Citations (22)

Originally described in: Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer.
Rudin CM, Durinck S, Stawiski EW, Poirier JT, Modrusan Z, Shames DS, Bergbower EA, Guan Y, Shin J, Guillory J, Rivers CS, Foo CK, Bhatt D, Stinson J, Gnad F, Haverty PM, Gentleman R, Chaudhuri S, Janakiraman V, Jaiswal BS, Parikh C, Yuan W, Zhang Z, Koeppen H, Wu TD, Stern HM, Yauch RL, Huffman KE, Paskulin DD, Illei PB, Varella-Garcia M, Gazdar AF, de Sauvage FJ, Bourgon R, Minna JD, Brock MV, Seshagiri S Nat Genet. 2012 Oct;44(10):1111-6. doi: 10.1038/ng.2405. Epub 2012 Sep 2. PubMed Journal

---

Articles Citing Tet-pLKO-puro-Scrambled

Articles
Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer. Lin CC, Lo MC, Moody R, Jiang H, Harouaka R, Stevers N, Tinsley S, Gasparyan M, Wicha M, Sun D. Cancer Lett. 2018 Dec 1;438:165-173. doi: 10.1016/j.canlet.2018.09.022. Epub 2018 Sep 15. PubMed
Identification of different gene expressions between diffuse- and intestinal-type spheroid-forming gastric cancer cells. Lee JW, Sung JS, Park YS, Chung S, Kim YH. Gastric Cancer. 2019 Feb 6. pii: 10.1007/s10120-019-00935-x. doi: 10.1007/s10120-019-00935-x. PubMed
The homeobox transcription factor MEIS2 is a regulator of cancer cell survival and IMiDs activity in Multiple Myeloma: modulation by Bromodomain and Extra-Terminal (BET) protein inhibitors. Abruzzese MP, Bilotta MT, Fionda C, Zingoni A, Soriani A, Petrucci MT, Ricciardi MR, Molfetta R, Paolini R, Santoni A, Cippitelli M. Cell Death Dis. 2019 Apr 11;10(4):324. doi: 10.1038/s41419-019-1562-9. PubMed
VDAC1 is regulated by BRD4 and contributes to JQ1 resistance in breast cancer. Yang G, Zhou D, Li J, Wang W, Zhong W, Fan W, Yu M, Cheng H. Oncol Lett. 2019 Sep;18(3):2340-2347. doi: 10.3892/ol.2019.10534. Epub 2019 Jun 27. PubMed
LCP1 triggers mTORC2/AKT activity and is pharmacologically targeted by enzastaurin in hypereosinophilia. Ma G, Gezer D, Herrmann O, Feldberg K, Schemionek M, Jawhar M, Reiter A, Brummendorf TH, Koschmieder S, Chatain N. Mol Carcinog. 2020 Jan;59(1):87-103. doi: 10.1002/mc.23131. Epub 2019 Nov 6. PubMed
KAP1 Is a Chromatin Reader that Couples Steps of RNA Polymerase II Transcription to Sustain Oncogenic Programs. Bacon CW, Challa A, Hyder U, Shukla A, Borkar AN, Bayo J, Liu J, Wu SY, Chiang CM, Kutateladze TG, D'Orso I. Mol Cell. 2020 Jun 18;78(6):1133-1151.e14. doi: 10.1016/j.molcel.2020.04.024. Epub 2020 May 12. PubMed
Contribution of GATA6 to homeostasis of the human upper pilosebaceous unit and acne pathogenesis. Oules B, Philippeos C, Segal J, Tihy M, Vietri Rudan M, Cujba AM, Grange PA, Quist S, Natsuga K, Deschamps L, Dupin N, Donati G, Watt FM. Nat Commun. 2020 Oct 20;11(1):5067. doi: 10.1038/s41467-020-18784-z. PubMed
Mitochondria Define Intestinal Stem Cell Differentiation Downstream of a FOXO/Notch Axis. Ludikhuize MC, Meerlo M, Gallego MP, Xanthakis D, Burgaya Julia M, Nguyen NTB, Brombacher EC, Liv N, Maurice MM, Paik JH, Burgering BMT, Rodriguez Colman MJ. Cell Metab. 2020 Nov 3;32(5):889-900.e7. doi: 10.1016/j.cmet.2020.10.005. PubMed
Growth of pancreatic cancers with hemizygous chromosomal 17p loss of MYBBP1A can be preferentially targeted by PARP inhibitors. Hsieh A, Pitarresi JR, Lerner J, Donahue G, Hsiehchen D, Rustgi AK, Zaret K. Sci Adv. 2020 Dec 4;6(49). pii: 6/49/eabc4517. doi: 10.1126/sciadv.abc4517. Print 2020 Dec. PubMed
NBS1-CtIP-mediated DNA end resection suppresses cGAS binding to micronuclei. Abdisalaam S, Mukherjee S, Bhattacharya S, Kumari S, Sinha D, Ortega J, Li GM, Sadek HA, Krishnan S, Asaithamby A. Nucleic Acids Res. 2022 Mar 21;50(5):2681-2699. doi: 10.1093/nar/gkac079. PubMed
Melanoma-Secreted Amyloid Beta Suppresses Neuroinflammation and Promotes Brain Metastasis. Kleffman K, Levinson G, Rose IVL, Blumenberg LM, Shadaloey SAA, Dhabaria A, Wong E, Galan-Echevarria F, Karz A, Argibay D, Von Itter R, Floristan A, Baptiste G, Eskow NM, Tranos JA, Chen J, Vega Y Saenz de Miera EC, Call M, Rogers R, Jour G, Wadghiri YZ, Osman I, Li YM, Mathews P, DeMattos RB, Ueberheide B, Ruggles KV, Liddelow SA, Schneider RJ, Hernando E. Cancer Discov. 2022 May 2;12(5):1314-1335. doi: 10.1158/2159-8290.CD-21-1006. PubMed
Microbial Metabolites Orchestrate a Distinct Multi-Tiered Regulatory Network in the Intestinal Epithelium That Directs P-Glycoprotein Expression. Foley SE, Dente MJ, Lei X, Sallis BF, Loew EB, Meza-Segura M, Fitzgerald KA, McCormick BA. mBio. 2022 Aug 30;13(4):e0199322. doi: 10.1128/mbio.01993-22. Epub 2022 Aug 15. PubMed
MicroRNA Content of Ewing Sarcoma Derived Extracellular Vesicles Leads to Biomarker Potential and Identification of a Previously Undocumented EWS-FLI1 Translocation. Crow J, Samuel G, Farrow E, Gibson M, Johnston J, Guest E, Miller N, Pei D, Koestler D, Pathak H, Liang X, Mangels C, Godwin AK. Biomark Insights. 2022 Oct 31;17:11772719221132693. doi: 10.1177/11772719221132693. eCollection 2022. PubMed
Exercise-activated hepatic autophagy via the FN1-alpha5beta1 integrin pathway drives metabolic benefits of exercise. Kuramoto K, Liang H, Hong JH, He C. Cell Metab. 2023 Apr 4;35(4):620-632.e5. doi: 10.1016/j.cmet.2023.01.011. Epub 2023 Feb 21. PubMed
DNA replication initiation factor RECQ4 possesses a role in antagonizing DNA replication initiation. Xu X, Chang CW, Li M, Omabe K, Le N, Chen YH, Liang F, Liu Y. Nat Commun. 2023 Mar 4;14(1):1233. doi: 10.1038/s41467-023-36968-1. PubMed
Distinct roles of SOX9 in self-renewal of progenitors and mesenchymal transition of the endothelium. Zhao J, Sormani L, Jacquelin S, Li H, Styke C, Zhou C, Beesley J, Oon L, Kaur S, Sim SL, Wong HY, Dight J, Hashemi G, Shafiee A, Roy E, Patel J, Khosrotehrani K. Angiogenesis. 2024 Aug;27(3):545-560. doi: 10.1007/s10456-024-09927-7. Epub 2024 May 11. PubMed
The clock gene BHLHE40 and atypical CCNG2 control androgen-induced cellular senescence as a novel tumor suppressive pathway in prostate cancer. Heidari Horestani M, Atri Roozbahani G, Baniahmad A. J Exp Clin Cancer Res. 2024 Jun 20;43(1):174. doi: 10.1186/s13046-024-03097-6. PubMed
High CDC20 levels increase sensitivity of cancer cells to MPS1 inhibitors. Zheng S, Raz L, Zhou L, Cohen-Sharir Y, Tian R, Ippolito MR, Gianotti S, Saad R, Wardenaar R, Broekhuis M, Suarez Peredo Rodriguez M, Wobben S, van den Brink A, Bakker P, Santaguida S, Foijer F, Ben-David U. EMBO Rep. 2025 Feb;26(4):1036-1061. doi: 10.1038/s44319-024-00363-8. Epub 2025 Jan 21. PubMed
A Novel Chemotherapy Combination to Enhance Proteotoxic Cell Death in Hepatocellular Carcinoma Experimental Models Without Killing Non-Cancer Cells. Perez-Stable C, de Las Pozas A, Reiner T, Gomez J, Nagarajan M, Foster RT, Ure DR, Wangpaichitr M. Int J Mol Sci. 2025 Jul 12;26(14):6699. doi: 10.3390/ijms26146699. PubMed
SOX2 utilizes FOXA1 as a heteromeric transcriptional partner to drive proliferation in therapy-resistant prostate cancer. Phoenix JT, Budreika A, Schmeck DA, Kostlan RJ, Ferrari MG, Young KS, Rogers CS, Deegan CD, Bienko MW, Bergom HE, Boytim E, Brown RM, Walewicz JA, Bhagi SK, Ellis L, Antonarakis ES, Drake JM, Bawa PS, Vellky JE, Williams A, Rezine NM, Rennhack JP, Fanning SW, Hwang JH, Szmulewitz RZ, Vander Griend DJ, Kregel S. bioRxiv [Preprint]. 2025 Jul 19:2025.07.18.664790. doi: 10.1101/2025.07.18.664790. PubMed
Cyclophilin Inhibitor Rencofilstat Combined with Proteasome Inhibitor Ixazomib Increases Proteotoxic Cell Death in Advanced Prostate Cancer Cells with Minimal Effects on Non-Cancer Cells. Perez-Stable C, de Las Pozas A, Wangpaichitr M, Foster RT, Ure DR. Biomedicines. 2025 Oct 7;13(10):2442. doi: 10.3390/biomedicines13102442. PubMed
NAT10 promotes cancer metastasis by modulating p300/CBP activity through chromatin-associated tRNA. Amin R, Ha NH, Qiu T, Holewinski R, Lam KC, Daugherty-Lopes A, Liu H, Tran AD, Lee MP, Andresson T, Goldszmid RS, Hunter KW. Mol Cell. 2025 Dec 18;85(24):4526-4544.e18. doi: 10.1016/j.molcel.2025.11.010. Epub 2025 Dec 3. PubMed

If you have published an article using this material, please email us at to have your article added to this page.